E.R. Squibb & Sons LLC | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

6,419 results for “E.R. Squibb & Sons LLC”

Trials

View all 2631 →

Recruiting African American Fathers/ Sons

28 participants · First posted Jun 23, 2016

Active, not recruiting

REsponse to Combined SONS and ONS in Chronic Cluster headachE

5 participants · First posted May 22, 2023

Bioequivalence Study of Sotalol, Tablets, 160 mg (Pharmtechnology LLC, Belarus), and Sotalex ®, Tablets, 160 mg (Bristol-Myers Squibb GmbH & Co. KGaA, Germany), in Healthy Volunteers Under Fasting Conditions

36 participants · First posted Jan 10, 2019

Drugs

View all 703 →

LLC-0424

IB-RA (Innobioscience LLC)

cancer therapeutics (evotec/Bristol-Myers Squibb)

Organizations

View all 1747 →

E.R. Squibb & Sons, L.L.C.

United States

BRISTOL MYERS SQUIBB

United States

NAINA MOHAMED & SONS PRIVATE LIMITED

Singapore

News

View all 1338 →

Indian Courts Strengthen Patent Opposition Framework in High-Profile Cancer Immunotherapy and Drug Delivery Cases

Delhi High Court Grants Interim Injunction Against Zydus Biosimilar to Protect Nivolumab Patent Rights

Travere Therapeutics Pauses Enrollment in Phase 3 Homocystinuria Trial Due to Manufacturing Issues

Page 1 of 642